Cointime

ViroXis

company

About

ViroXis, a bio-pharmaceutical company, develops botanical pharmaceuticals derived from sandalwood oil.

  • 11 - 50

Highlights

Total Funding Amount
$1.01M
Funding Rounds
1
Investors
1

Details

Last Funding Type
Series Unknown
Last Funding Money Raised
$1.01M
Industries
Biotechnology,Health Care,Pharmaceutical
Founded date
Jan 1, 2006
Number Of Employee
11 - 50
Operating Status
Close

ViroXis is a bio-pharmaceutical company focused on developing and commercializing innovative, properietary, botanical pharmaceuticals derived from Sandalwood Oil. The hardwood oils of the East Indian and West Australian sandalwood trees, S.album and S. spicatum, have a long and extensive history of traditional use for a variety of conditions, including the successful treatment of various skin disorders, including skin viral and difficult-to-treat microbial infections.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
$1.01M
ViroXis has raised a total of $1.01M in funding over 2 rounds. Their latest funding was raised on Mar 31, 2012 from a Series Unknown round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Mar 31, 2012 Series Unknown $1.01M 1 — — Detail

Investors

Number of Lead Investors
Number of Investors
—
1
ViroXis is funded by 1 investors. Greer Capital Advisors are the most recent investors.
Investor Name Lead Investor Funding Round
Greer Capital Advisors — Series Unknown
Cointime
เนื้อหา
บริษัท